Company
COO
Christine Baker
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christine Baker
The company reported in an 8-K filed October 20, 2023 that Christine Baker resigned as Chief Operating Officer, effective October 16, 2023. The proxy statement of the company reports total compensation of $813,399 for Christine Baker in fiscal 2023, including a base salary of $477,000. Disclosed compensation is on record for 3 fiscal years.
“On October 20, 2023, HOOKIPA Pharma Inc. (the "Company") announced that Christine Baker, the Company's Chief Operating Officer, resigned on October 16, 2023 and will be leaving the Company on January 15, 2024, following a garden leave period commencing on November 1, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
Proxy statement
Start not stated–2021-04-20
Last confirmed by a filing; no departure on record
-
Organization not stated
COO
Proxy statement
Start not stated–2023-10-16
-
Organization not stated
COO
Proxy statement
Start not stated–2023-10-16
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | — | Former Chief Operating Officer | $477,000 | $813,399 |
| 2022 | — | Former Chief Operating Officer | $394,263 | $873,624 |
| 2021 | — | Chief Operating Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Resigned: Chief Operating Officer